Long-term outcomes and predictors of disabling disease in a population-based cohort of patients with incident Crohn's disease diagnosed between 1994 and 1997

被引:1
|
作者
Rabilloud, Marie-Laure [1 ]
Bajeux, Emma [2 ]
Siproudhis, Laurent [3 ]
Hamonic, Stephanie [2 ]
Pagenault, Mael [1 ]
Brochard, Charlene [3 ]
Gerfaud, Agathe [4 ]
Dabadie, Alain [4 ]
Viel, Jean-Francois
Tron, Isabelle [5 ]
Robaszkiewicz, Michel [6 ]
Bretagne, Jean-Francois [1 ,2 ]
Bouguen, Guillaume [3 ]
机构
[1] Univ Rennes, CHU Rennes, F-35000 Rennes, France
[2] Univ Hosp Pontchaillou, Dept Publ Hlth, Rennes, France
[3] Univ Rennes, CHU Rennes, INSERM, CIC1414,Inst NUMECAN Nutr Metab & Canc, F-35000 Rennes, France
[4] Hop Sud, Paediat Unit, CHU Rennes, Rennes, France
[5] Observ Reg Sante Bretagne, Rennes, France
[6] Univ Brest, CHU Brest, F-29000 Brest, France
关键词
Crohn's disease; Population-based; Outcomes; INFLAMMATORY-BOWEL-DISEASE; NATURAL-HISTORY; SURGERY; INFLIXIMAB; MANAGEMENT; CLASSIFICATION; BEHAVIOR; THERAPY; RATES; ERA;
D O I
10.1016/j.clinre.2022.101974
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The identification of early prognostic factors during Crohn's disease (CD) remains needed for physician decision-making to minimize structural bowel damage, which this study aimed to assess in a population-based setting. Methods: All incident cases of CD were prospectively registered from 1994 to 1997 in Brittany, a limited area of France. All charts of patients were reviewed from the diagnosis to the last clinic visit in 2015. Disabling CD course was defined according to the Saint-Antoine criteria. Results: Among the 331 incident cases of CD, 272 (82%) were followed-up for a median time of 12.8 years. The cumulative probability of developing stricturing or fistulizing CD was 66% at 15 years, and 107 (39%) patients underwent surgery. The cumulative probabilities of immunosuppressant and TNF antagonist use at 15 years were 37% and 22%, respectively. The cumulative risks for disabling disease and bowel damage were 74% and 71% at 15 years, respectively. Systemic symptoms and perianal lesions at diagnosis were independently associated with a disabling disease course. Perianal disease and short disease extension were associated with the onset of bowel damage. Deep ulcers was not predictive of any outcome. Conclusions: A disabling disease course and bowel damage occurred early in the course of CD, which suggests the need for early diagnosis and early treatment, particularly for patients with systematic symptoms and perianal disease. (c) 2022 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Long-Term Outcomes in ICU Patients with Delirium A Population-based Cohort Study
    Fiest, Kirsten M.
    Soo, Andrea
    Lee, Chel Hee
    Niven, Daniel J.
    Ely, E. Wesley
    Doig, Christopher J.
    Stelfox, Henry T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 204 (04) : 412 - 420
  • [42] Clinical outcomes and long-term prognosis of perianal Crohn's disease in an Asian population
    Song, Eun Mi
    Lee, Ho-Su
    Kim, Ye-Jee
    Oh, Eun Hye
    Ham, Nam Seok
    Kim, Jeongseok
    Hwang, Sung Wook
    Park, Sang Hyoung
    Yang, Dong-Hoon
    Ye, Byong Duk
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (06) : 1571 - 1579
  • [43] Long-term Rifaximin Treatment for Newly Diagnosed Crohn's Disease
    Shafran, I
    Burgunder, P.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S44 - S45
  • [44] Understanding Infliximab in Crohn's Disease: The Long-Term Outcomes
    Turner, Dan
    Lev-Tzion, Raffi
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (03) : 604 - 607
  • [45] Outcomes of Crohn's Disease in Females: A Population-Based Study
    Elias, Toy
    Beshai, Rafail
    Weinberg, Howard
    Wadehra, Ramneet
    Soliman, Joshua
    Mounas, Petter
    Rofail, Priscilla
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S38 - S38
  • [46] Understanding Infliximab in Crohn’s Disease: The Long-Term Outcomes
    Dan Turner
    Raffi Lev-Tzion
    Digestive Diseases and Sciences, 2013, 58 : 604 - 607
  • [47] Long-term outcomes of thalidomide in pediatric Crohn's disease
    Wang, Lin
    Xue, Aijuan
    Zheng, Cuifang
    Zhou, Ying
    Wang, Yuhuan
    Huang, Ying
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (07) : 1124 - 1129
  • [48] Long-term outcomes of thalidomide in refractory Crohn's disease
    Gerich, M. E.
    Yoon, J. L.
    Targan, S. R.
    Ippoliti, A. F.
    Vasiliauskas, E. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (05) : 429 - 437
  • [49] Early anti-TNF treatment in pediatric Crohn's disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients
    Olbjorn, Christine
    Nakstad, Britt
    Smastuen, Milada C.
    Thiis-Evensen, Espen
    Vatn, Morten H.
    Perminow, Gori
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (12) : 1425 - 1431
  • [50] Long-term Clinical Outcomes of Crohn's Disease and Intestinal Behcet's Disease
    Jung, Yoon Suk
    Cheon, Jae Hee
    Park, Soo Jung
    Hong, Sung Pil
    Kim, Tae Il
    Kim, Won Ho
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (01) : 99 - 105